IMED Stock Overview
A research and development partnership, focuses on investing in research projects and development in the medical field, primarily the digital health field.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Imed Infinity Medical-Limited Partnership Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₪1.10 |
| 52 Week High | ₪1.89 |
| 52 Week Low | ₪0.58 |
| Beta | 0.069 |
| 11 Month Change | 1.57% |
| 3 Month Change | -8.92% |
| 1 Year Change | n/a |
| 33 Year Change | -58.39% |
| 5 Year Change | n/a |
| Change since IPO | -88.96% |
Recent News & Updates
Recent updates
Shareholder Returns
| IMED | IL Medical Equipment | IL Market | |
|---|---|---|---|
| 7D | 0% | 1.0% | 2.8% |
| 1Y | n/a | 22.2% | 30.0% |
Return vs Industry: Insufficient data to determine how IMED performed against the IL Medical Equipment industry.
Return vs Market: Insufficient data to determine how IMED performed against the IL Market.
Price Volatility
| IMED volatility | |
|---|---|
| IMED Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 5.8% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in IL Market | 7.3% |
| 10% least volatile stocks in IL Market | 2.8% |
Stable Share Price: IMED's share price has been volatile over the past 3 months compared to the IL market.
Volatility Over Time: Insufficient data to determine IMED's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | 55 | Itay Gal-Or | www.infinitymedical.co.il/ |
Imed Infinity Medical-Limited Partnership, a research and development partnership, focuses on investing in research projects and development in the medical field, primarily the digital health field. The company was incorporated in 2020 and is based in Tel Aviv, Israel.
Imed Infinity Medical-Limited Partnership Fundamentals Summary
| IMED fundamental statistics | |
|---|---|
| Market cap | ₪4.45m |
| Earnings (TTM) | -₪4.43m |
| Revenue (TTM) | n/a |
-2.4x
P/S Ratio-1.0x
P/E RatioIs IMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IMED income statement (TTM) | |
|---|---|
| Revenue | -US$495.00k |
| Cost of Revenue | US$0 |
| Gross Profit | -US$495.00k |
| Other Expenses | US$687.00k |
| Earnings | -US$1.18m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.29 |
| Gross Margin | 100.00% |
| Net Profit Margin | 238.79% |
| Debt/Equity Ratio | 0% |
How did IMED perform over the long term?
See historical performance and comparison